- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05380661
Heart Rate Variability and Anxiety During Urinary Bladder Catheterization
April 27, 2026 updated by: Andrei Krassioukov, University of British Columbia
Heart Rate Variability During Urinary Bladder Catheterization in Individuals With Spinal Cord Injury: Anxiety Versus Sensory Discomfort
This is a prospective, randomised study investigating the physical and psychological experience of intermittent catheterization in adult individuals following spinal cord injury (SCI).
Study Overview
Status
Completed
Conditions
Detailed Description
Given that intermittent catheterization is the recommended method of bladder management in individuals with SCI, it is crucial that the potentially negative cardiovascular and psychological responses to this procedure are examined.
Individuals will undergo self-catheterization, then two standard of care catheterization procedures performed by an experienced urology nurse, while either blinded to or aware of time of catheterization.
Continuous cardiovascular monitoring will be in place throughout all three procedures.
Assessment of anxiety will be administered pre- and post- each procedure.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 1M9
- Blusson Spinal Cord Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 66 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Male or female, 18-70 years of age
- Any chronic traumatic SCI with either motor sensory complete injury (AIS A/B, N=10) or motor sensory incomplete injury (AIS B/D, N=10).
- At least 1 year post injury, and at least 6 months from any spinal surgery
- Hand function sufficient to perform intermittent catheterization for management of urinary bladder drainage
- Must provide informed consent and be able to understand and complete study-related questionnaires (must be able to understand and speak English or have access to an appropriate interpreter as judged by the investigator)
- Willing and able to comply with clinic visit and study-related procedures
Exclusion Criteria:
- Signs or known current urinary tract infection, or other inflammatory conditions of bladder/urethra
- Currently taking beta blockers or other medications that may affect heart rate
- History of ureteral injury
- History of any urinary diversion procedures, including but not limited to bladder augmentation, cystectomy, neo bladder, pouch reservoir, ileal conduit, Mitrofanoff appendicovesicostomy
- For women of childbearing potential, currently pregnant
- A member of the investigational team or his/her immediate family Presence of severe acute medical issue and use of any specific medication or treatment that, in the investigator's judgement, would adversely affect the participant's participation in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Individuals with motor-complete SCI
Individuals with motor sensory complete injury (AIS A/B)
|
Participants will perform self-catheterization, following the same routine for intermittent catheterization at home
Participant will undergo procedure to completely empty bladder; Participant in supine position, and resting blood pressure and heart rate will be recorded for period of 5 minutes prior to catheterization; Perineum and genital areas will be draped and they will be not aware about exact timing of catheterization Catheterization will be conducted following standard clinic procedure by experience urology nurse.
Participant will undergo procedure to completely empty bladder; Participant in supine position, and resting BP and HR will be recorded for period of 5 minutes prior to catheterization; Perineum and genital areas will be visible to participant and they will be fully aware about exact timing of catheterization Catheterization will be conducted following standard clinic procedure by experience urology nurse.
|
|
Experimental: Individuals with motor-incomplete SCI
Individuals with motor sensory incomplete injury (AIS C/D)
|
Participants will perform self-catheterization, following the same routine for intermittent catheterization at home
Participant will undergo procedure to completely empty bladder; Participant in supine position, and resting blood pressure and heart rate will be recorded for period of 5 minutes prior to catheterization; Perineum and genital areas will be draped and they will be not aware about exact timing of catheterization Catheterization will be conducted following standard clinic procedure by experience urology nurse.
Participant will undergo procedure to completely empty bladder; Participant in supine position, and resting BP and HR will be recorded for period of 5 minutes prior to catheterization; Perineum and genital areas will be visible to participant and they will be fully aware about exact timing of catheterization Catheterization will be conducted following standard clinic procedure by experience urology nurse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure (BP) during self-catheterization
Time Frame: During self-catheterization
|
Systolic and diastolic BP (mmHg) will be measured continuously (beat-by-beat) via finger photoplethysmography, corrected to brachial pressure.
BP will be measured 5 minutes prior to and then throughout the self-catheterization procedure.
|
During self-catheterization
|
|
Heart rate (HR) during self-catheterization
Time Frame: During self-catheterization
|
HR (BPM) will be recorded continuously via one-lead electrocardiogram.
HR will be measured 5 minutes prior to and then throughout the self-catheterization procedure.
|
During self-catheterization
|
|
BP during catheterization performed by urology nurse, participant blinded to time of procedure
Time Frame: During catheterization performed by urology nurse, participant blinded to time of procedure
|
Systolic and diastolic BP (mmHg) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is blinded to time of procedure.
|
During catheterization performed by urology nurse, participant blinded to time of procedure
|
|
HR during catheterization performed by urology nurse, participant blinded to time of procedure
Time Frame: During catheterization performed by urology nurse, participant blinded to time of procedure
|
HR (BPM) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is blinded to time of procedure.
|
During catheterization performed by urology nurse, participant blinded to time of procedure
|
|
BP during catheterization performed by urology nurse, participant aware of time of procedure
Time Frame: During catheterization performed by urology nurse, participant aware of time of procedure
|
Systolic and diastolic BP (mmHg) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is aware of time of procedure.
|
During catheterization performed by urology nurse, participant aware of time of procedure
|
|
HR during catheterization performed by urology nurse, participant aware of time of procedure
Time Frame: During catheterization performed by urology nurse, participant aware of time of procedure
|
HR (BPM) will be measured 5 minutes prior to and then throughout the standard of care catheterization performed by an experienced urology nurse, while the participant is aware of time of procedure.
|
During catheterization performed by urology nurse, participant aware of time of procedure
|
|
Change in state anxiety in the context of self-catheterization (STAIS-5)
Time Frame: 5 minutes before and 5 minutes after self-catheterization
|
The State-Trait Anxiety Inventory - State, 5 item version (STAIS-5) will be used to measure participants' state anxiety prior to and after self-catheterization. Sum score of the STAIS-5 will be calculated, which ranges between 5 to 20, with higher score indicating greater state anxiety.
|
5 minutes before and 5 minutes after self-catheterization
|
|
Change in state anxiety in the context of catheterization performed by urology nurse, participant blinded to time of procedure (STAIS-5)
Time Frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant blinded to time of procedure
|
The STAIS-5 will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is blinded to time of procedure.
Sum score of the STAIS-5 will be calculated, which ranges between 5 to 20, with higher score indicating greater state anxiety.
|
5 minutes before and 5 minutes after catheterization performed by urology nurse, participant blinded to time of procedure
|
|
Change in state anxiety in the context of catheterization performed by urology nurse, participant aware of time of procedure (STAIS-5)
Time Frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant aware of time of procedure
|
The STAIS-5 will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is aware of time of procedure.
Sum score of the STAIS-5 will be calculated, which ranges between 5 to 20, with higher score indicating greater state anxiety.
|
5 minutes before and 5 minutes after catheterization performed by urology nurse, participant aware of time of procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baseline trait anxiety
Time Frame: During screening
|
The 7-item General Anxiety Disorder (GAD) scale will be used to measure participants' anxiety.
The GAD-7 sum score will be calculated, ranging from 0 to 21, with higher score indicating more severe anxiety symptoms.
|
During screening
|
|
Change in state anxiety in the context of self-catheterization (GA-VAS)
Time Frame: 5 minutes before and 5 minutes after self-catheterization
|
The Global Anxiety-Visual Analogue Scale (GA-VAS) will be used to measure participants' state anxiety prior to and after self-catheterization. Rating can range between 0 to 10, with higher rating on the GA-VAS indicates greater state anxiety.
|
5 minutes before and 5 minutes after self-catheterization
|
|
Change in state anxiety in the context of catheterization performed by urology nurse, participant blinded to time of procedure (GA-VAS)
Time Frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant blinded to time of procedure
|
The GA-VAS will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is blinded to time of procedure.
Rating can range between 0 to 10, higher rating on the GA-VAS indicates greater state anxiety.
|
5 minutes before and 5 minutes after catheterization performed by urology nurse, participant blinded to time of procedure
|
|
Change in state anxiety in the context of catheterization performed by urology nurse, participant aware of time of procedure (GA-VAS)
Time Frame: 5 minutes before and 5 minutes after catheterization performed by urology nurse, participant aware of time of procedure
|
The GA-VAS will be used to measure participants' state anxiety prior to and after catheterization procedure performed by an experienced urology nurse, while the participant is aware of time of procedure.
Higher rating on the GA-VAS indicates greater state anxiety.
|
5 minutes before and 5 minutes after catheterization performed by urology nurse, participant aware of time of procedure
|
|
Change in heart rate variability (HRV) during self-catheterization
Time Frame: During self-catheterization
|
HRV will be calculated from continuous ECG recording
|
During self-catheterization
|
|
Change in heart rate variability (HRV) during catheterization performed by urology nurse, participant blinded to time of procedure
Time Frame: During catheterization performed by urology nurse, participant blinded to time of procedure
|
HRV will be calculated from continuous ECG recording
|
During catheterization performed by urology nurse, participant blinded to time of procedure
|
|
Change in heart rate variability (HRV) during catheterization performed by urology nurse, participant aware of time of procedure
Time Frame: During catheterization performed by urology nurse, participant aware of time of procedure
|
HRV will be calculated from continuous ECG recording
|
During catheterization performed by urology nurse, participant aware of time of procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrei Krassioukov, MD,PhD,FRCPC, University of British Columbia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2022
Primary Completion (Actual)
April 16, 2026
Study Completion (Actual)
April 16, 2026
Study Registration Dates
First Submitted
May 5, 2022
First Submitted That Met QC Criteria
May 13, 2022
First Posted (Actual)
May 19, 2022
Study Record Updates
Last Update Posted (Actual)
April 28, 2026
Last Update Submitted That Met QC Criteria
April 27, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Neurologic Manifestations
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Wounds and Injuries
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Trauma, Nervous System
- Urinary Bladder Diseases
- Spinal Cord Diseases
- Autonomic Nervous System Diseases
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Anxiety Disorders
- Spinal Cord Injuries
- Urinary Bladder, Neurogenic
- Autonomic Dysreflexia
- Investigative Techniques
- Therapeutics
- Catheterization
- Urinary Catheterization
- Intermittent Urethral Catheterization
Other Study ID Numbers
- H22-00971
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.